These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3194355)

  • 21. Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment.
    Matloff DS; Kaplan MM; Neer RM; Goldberg MJ; Bitman W; Wolfe HJ
    Gastroenterology; 1982 Jul; 83(1 Pt 1):97-102. PubMed ID: 7075948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and management of osteoporosis.
    Lukert BP
    Compr Ther; 1984 Dec; 10(12):8-14. PubMed ID: 6518738
    [No Abstract]   [Full Text] [Related]  

  • 23. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.
    Civitelli R; Gonnelli S; Zacchei F; Bigazzi S; Vattimo A; Avioli LV; Gennari C
    J Clin Invest; 1988 Oct; 82(4):1268-74. PubMed ID: 3262626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of patients with postmenopausal and steroid-induced osteoporosis using sodium fluoride combined with vitamin D2 and calcium gluconate].
    Todorova S; Diankova L; Andreeva M; Khristova D; Tsachev K; Kamenova P
    Vutr Boles; 1990; 29(1):77-81. PubMed ID: 2396420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Recent acquisitions in therapy of osteoporosis of various etiologies with calcitonin].
    Vigo PL; Di Ciano L; Girardello R; Reschini E; Polli E
    Recenti Prog Med; 1977 Jun; 62(6):649-70. PubMed ID: 578332
    [No Abstract]   [Full Text] [Related]  

  • 26. Changes in bone histomorphometry and bone mineral during treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium.
    Lindholm TS; Nilsson OS; Elmstedt E; Eriksson SA; Lindholm TC; Kyhle BR
    Acta Vitaminol Enzymol; 1981; 3(3):170-6. PubMed ID: 7347489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Observations with anteovin in family planning advisory unit.
    Domány Z
    Ther Hung; 1988; 36(1):29-33. PubMed ID: 3388289
    [No Abstract]   [Full Text] [Related]  

  • 28. Postmenopausal osteoporosis: treatment with low-dose sodium fluoride and estrogen.
    Lueg MC
    South Med J; 1988 May; 81(5):597-600. PubMed ID: 2835819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined treatment of post-menopausal osteoporosis: effect on muscle function and a new radiological method for assessing trabecular bone.
    Crisp AJ; Buckland-Wright JC; Kauffmann EA; Gibson T
    Curr Med Res Opin; 1984; 8(10):701-7. PubMed ID: 6723347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of spinal calcium by in vivo neutron activation analysis in osteoporosis.
    Smith MA; Eastell R; Kennedy NS; McIntosh LG; Simpson JD; Strong JA; Tothill P
    Clin Phys Physiol Meas; 1981 Feb; 2(1):45-8. PubMed ID: 7338015
    [No Abstract]   [Full Text] [Related]  

  • 31. Vitamin-D analogues and renal function.
    Lancet; 1978 Dec; 2(8102):1259-60. PubMed ID: 82768
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of osteoporosis with calcitonin, with and without growth hormone.
    Aloia JF; Vaswani A; Kapoor A; Yeh JK; Cohn SH
    Metabolism; 1985 Feb; 34(2):124-9. PubMed ID: 3969014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Osteoporosis in patients with diabetes mellitus type 1 and 2. Roentgeno-morphometric evaluation and changes in various parameters of calcium-phosphorus metabolism].
    Gasińska T
    Pol Tyg Lek; 1984 Apr; 39(18):603-7. PubMed ID: 6536932
    [No Abstract]   [Full Text] [Related]  

  • 34. Interim report on treatment of osteoporotic patients with 1 alpha-hydroxyvitamin D3 and calcium.
    Lindholm TS; Sevastikoglou JA; Lindgren U
    Clin Orthop Relat Res; 1978 Sep; (135):232-40. PubMed ID: 709936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Replacement hormonal therapy in correction of metabolic-trophic changes in ovarian failure syndrome].
    Kuznetsov SIu
    Akush Ginekol (Mosk); 1995; (3):38-41. PubMed ID: 7653728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Changes in various parameters of calcium-phosphorus metabolism, roentgenomorphometric indicators in selected bones and results of the calcitonin test in patients with hyperthyroidism].
    Gasińska T; Drozdz M; Izbicka M; Nawrat T; Beldzik A
    Endokrynol Pol; 1986; 37(2):75-84. PubMed ID: 3780573
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of the drug therapy for established osteoporosis by dual-energy x-ray absorptiometry.
    Shiota E
    Fukuoka Igaku Zasshi; 1998 Jun; 89(6):172-8. PubMed ID: 9695314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Synthetic human calcitonin in Paget's disease of bone and osteoporosis (author's transl)].
    Nuti R; Vattimo A
    Dtsch Med Wochenschr; 1981 Jan; 106(5):149-52. PubMed ID: 6162631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experience in treating metabolic osteopathies with 1 alpha-hydroxyvitamin D3 (oksidevit)].
    Babarykin DA; Reĭsner NA; Riabukha AN; Rozental' RL
    Ter Arkh; 1991; 63(11):113-6. PubMed ID: 1810042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of post-menopausal osteoporosis with phosphate and intermittent calcitonin.
    Kuntz D; Marie P; Berhel M; Caulin F
    Int J Clin Pharmacol Res; 1986; 6(2):157-62. PubMed ID: 3522444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.